Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab

Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab

<p><strong>Objectives</strong></p><p>Treat to target recommendations for PsA state that the target of treatment should be remission or, at the very least, low disease activity. Different clinical indexes have been proposed to define these disease states including the mi...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Coates, L, Rahman, P, Psaradellis, E, Rampakakis, E, Osborne, B, Lehman, A, Nantel, F
Fformat:	Journal article
Cyhoeddwyd:	Oxford University Press 2018

Eitemau Tebyg

Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry
gan: Emmanouil Rampakakis, et al.
Cyhoeddwyd: (2020-08-01)

Golimumab for the treatment of psoriatic arthritis
gan: H Yang, et al.
Cyhoeddwyd: (2011-05-01)

Golimumab in the treatment of psoriatic arthritis: efficacy and safety
gan: Tatiana Viktorovna Korotaeva, et al.
Cyhoeddwyd: (2015-09-01)

Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry
gan: Proton Rahman, et al.
Cyhoeddwyd: (2020-09-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
gan: M. Rossini, et al.
Cyhoeddwyd: (2015-03-01)

Sustained very low disease activity and remission in psoriatic arthritis patients
gan: Lubrano, E, et al.
Cyhoeddwyd: (2019)

Considerations for the definition of remission criteria in psoriatic arthritis
gan: Mease, P, et al.
Cyhoeddwyd: (2017)

Golimumab for Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis: Pharmacologic and Clinical Considerations
gan: Sydney Moore McIntosh, et al.
Cyhoeddwyd: (2023-07-01)

Role of golimumab, a TNF-alpha inhibitor, in the treatment of the psoriatic arthritis
gan: Melissa A Michelon, et al.
Cyhoeddwyd: (2010-05-01)

Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients
gan: Ennio Lubrano, et al.
Cyhoeddwyd: (2019-08-01)

Long-term effectiveness and safety of infliximab and golimumab in ankylosing spondylitis patients from a Canadian prospective observational registry
gan: Proton Rahman, et al.
Cyhoeddwyd: (2020-11-01)

Remission in psoriatic arthritis—where are we now?
gan: Coates, L, et al.
Cyhoeddwyd: (2017)

What should be the primary target of "treat to target" in psoriatic arthritis?
gan: Coates, LC, et al.
Cyhoeddwyd: (2018)

Ideal target for psoriatic arthritis? Comparison of remission and low disease activity states in a real-life cohort
gan: van Mens, L, et al.
Cyhoeddwyd: (2017)

Comparison of different remission and low disease definitions in patients with psoriatic arthritis and evaluation of their prognostic value
gan: Coates, LC, et al.
Cyhoeddwyd: (2018)

Novel concepts in psoriatic arthritis management: Can we treat to target?
gan: Tucker, L, et al.
Cyhoeddwyd: (2018)

Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era
gan: Coates, L, et al.
Cyhoeddwyd: (2022)

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
gan: M. Elaine Husni, et al.
Cyhoeddwyd: (2022-03-01)

Ixekizumab makes very low disease activity and remission with psoriatic arthritis disease activity score possible in active psoriatic arthritis patients for up to 1 year: spirit-p1 and spirit-p2 trials
gan: Coates, L, et al.
Cyhoeddwyd: (2018)

Mixed methods study of clinicians’ perspectives on barriers to implementation of treat to target in psoriatic arthritis
gan: Dures, E, et al.
Cyhoeddwyd: (2020)

THE EFFECT OF GOLIMUMAB ON ARTERIAL STIFFNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS
gan: L. A. Knyazeva, et al.
Cyhoeddwyd: (2018-03-01)

Evaluation of Improvement in Skin and Nail Psoriasis in Bio‐naïve Patients With Active Psoriatic Arthritis Treated With Golimumab: Results Through Week 52 of the GO‐VIBRANT Study
gan: Philip Mease, et al.
Cyhoeddwyd: (2020-11-01)

Using etanercept to maintain remission of psoriatic arthritis during pregnancy
gan: Ibrahim A Al-Homood, et al.
Cyhoeddwyd: (2014-01-01)

2-years outcomes of the treat-to-target strategy in early psoriatic arthritis
gan: E. Yu. Loginova, et al.
Cyhoeddwyd: (2022-11-01)

GOLIMUMAB SIGNIFICANTLY IMPROVES SELF-REPORTED PRODUCTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS
gan: Wordsworth, P, et al.
Cyhoeddwyd: (2009)

Difficult-to-treat psoriatic arthritis. Data from the All-Russian registry of patients with psoriatic arthritis
gan: E. Yu. Loginova, et al.
Cyhoeddwyd: (2024-10-01)

Use of a multidimensional RAPID3 questionnaire to assess the achievement of remission and minimal disease activity in patients with early psoriatic arthritis treated according to Treat-to-target strategy
gan: E. Yu. Loginova, et al.
Cyhoeddwyd: (2019-01-01)

Psoriatic arthritis: prospects for the future
gan: Hackett, S, et al.
Cyhoeddwyd: (2022)

Maintenance of efficacy and safety with subcutaneous golimumab among patients with active rheumatoid arthritis who previously received intravenous golimumab.
gan: Taylor, P, et al.
Cyhoeddwyd: (2011)

Measuring outcomes in psoriatic arthritis
gan: Ogdie, A, et al.
Cyhoeddwyd: (2020)

Association between obesity and likelihood of remission or low disease activity status in psoriatic arthritis applying index-based and patient-based definitions of remission: a cross-sectional study
gan: Leung, Y-Y, et al.
Cyhoeddwyd: (2023)

Psoriatic arthritis
gan: FitzGerald, O, et al.
Cyhoeddwyd: (2021)

Psoriatic arthritis: prospects for the future
gan: Simon Hackett, et al.
Cyhoeddwyd: (2022-03-01)

Golimumab therapy-induced indicators of X-ray inflammation progression and magnitude according to magnetic resonance imaging evidence in patients with rheumatoid arthritis, ankylosing spondylitis, or psoriatic arthritis
gan: Aleksandr Viktorovich Smirnov
Cyhoeddwyd: (2013-06-01)

The road to personalised medicine in psoriatic arthritis
gan: White, JPE, et al.
Cyhoeddwyd: (2021)

Psoriatic arthritis: An up to date overview
gan: Simon Hackett, et al.
Cyhoeddwyd: (2020-01-01)

Tapering and discontinuation of biologics in patients with psoriatic arthritis with low disease activity
gan: Ye, W, et al.
Cyhoeddwyd: (2018)

Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries
gan: Gorlier, C, et al.
Cyhoeddwyd: (2018)

Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
gan: Sofia Lanz, et al.
Cyhoeddwyd: (2021-08-01)

Remission of psoriasis and psoriatic arthritis during bevacizumab therapy for renal cell cancer
gan: Ananaya Datta-Mitra, et al.
Cyhoeddwyd: (2014-01-01)